Diabetes Drug Class Appears to Reduce Recurrent Gout Flares
Previously associated with a lower incidence of gout, sodium-glucose cotransporter-2 (SGLT2) inhibitors for the first time also appear to reduce gout flare recurrence and excess mortality.
Source: medscape.com